Seeing Xiao Qian's blissful smile as a new mother brings back memories of the heartbreaking scene that unfolded three years ago:
At that time, Xiao Qian, five months pregnant, was diagnosed with "severe systemic lupus erythematosus." Swollen all over, with red rashes on her face and cracked lips, she weakly pleaded with the doctor: "Doctor, please save my baby. If I can hold on for three more months, there's a chance the child will survive." Yet given her condition, even a few more days of delay could have cost both lives.After obtaining consent from Xiaoqian's husband and parents, the doctor disregarded her request and sacrificed the fetus to save her life. Once out of danger, Xiaoqian blamed the doctor for not preserving her child. When the doctor explained she could still conceive after her condition stabilized, she looked utterly incredulous—she had long been told lupus made pregnancy impossible.
Indeed, until around 1990, medical professionals advised lupus patients against pregnancy. On one hand, treatments were ineffective back then, with few patients achieving remission. On the other, pregnancy during active disease often triggered lupus flare-ups, sometimes with life-threatening consequences.Today, however, the notion that "lupus patients should live and have children just like healthy individuals" is no longer an empty promise. Over the past decade or so, treatment efficacy for lupus has significantly improved, with most patients achieving remission. Once remission is attained, many patients can fulfill their desire to have children.
Timing is Key to Minimizing Risks
The prerequisite for pregnancy with lupus is achieving disease remission. While corticosteroids may alleviate symptoms, inducing remission requires immunosuppressive therapy. Once remission is attained, patients can discuss optimal timing for pregnancy with their physician to ensure maternal safety and fetal health.
Patients in complete remission may conceive and deliver like the general population;10%–30% experience disease flares during pregnancy requiring outpatient medication adjustments; approximately 10% require hospitalization for lupus treatment; only a very small number experience significant disease worsening necessitating pregnancy termination for maternal treatment. As with non-pregnant lupus patients, individual cases may face life-threatening relapses.
Given estrogen's significant role in lupus pathogenesis, hormonal shifts during pregnancy—particularly elevated estrogen and prolactin levels—sustain heightened immune responses. Thus, while most lupus patients can achieve successful pregnancy and childbirth, risks of disease activity and symptom exacerbation persist.Furthermore, the increased metabolic demands of the fetus during pregnancy place greater stress on the mother's heart and kidneys, placing her in a state of stress that can also trigger lupus flare-ups.Medication choices must prioritize fetal safety. Oral azathioprine in late pregnancy has minimal fetal impact, whereas dexamethasone, cyclophosphamide, and methotrexate can impair fetal development and are contraindicated during pregnancy. In severe cases, pregnancy termination may be necessary to administer high-dose corticosteroids or cyclophosphamide to save the mother.Thorough communication between physician and patient is essential to determine the optimal management plan. Childbirth causes a significant increase in maternal prolactin levels, while elevated estrogen levels take several months postpartum to gradually decline to non-pregnant levels. Consequently, the months following delivery represent a high-risk period for lupus recurrence.Historically, medical practice advocated initiating high-dose corticosteroids and immunosuppressants immediately postpartum. Although these medications represent a significant burden for the weakened postpartum mother, this approach was considered necessary to prevent lupus flare-ups.
Fortunately, recent studies have shown that administering oral bromocriptine for two weeks postpartum can rapidly reduce prolactin and estrogen levels to non-pregnant levels, thereby preventing postpartum lupus recurrence.
Timing is Key
There is no universal standard for the optimal timing of pregnancy and childbirth for lupus patients. Generally, pregnancy may be considered when: - Glucocorticoid dosage is reduced to a low level (prednisone ≤10 mg daily) and maintained at this dose for over six months; - Follow-up blood tests for lupus-related markers show stable results; and - Urinalysis is normal.If mild disease fluctuations occur after six months of low-dose maintenance, pregnancy decisions should be made based on individual circumstances. This requires thorough discussion with an experienced physician regarding pregnancy risks. For mildly active disease, pregnancy risks increase during gestation but most cases proceed successfully, depending on the couple's urgency to conceive. Moderately active disease warrants postponing pregnancy to prioritize disease control.
While most patients achieve complete remission, over half experience relapse at some point post-remission. Approximately 20% never attain full remission, maintaining only long-term control at moderate to low disease activity levels. Thus, lupus patients must carefully time pregnancy.
For those planning pregnancy, the optimal timing should be discussed with their physician once complete remission is achieved. This allows for planned medication adjustments and structured pregnancy management. Some patients may not wish to conceive when conditions are favorable, only to find their disease unstable when they later decide to have children, leading to regret.